Performance of Protein Induced by Vitamin K Absence or Antagonist-II (PIVKA-II) for Hepatocellular Carcinoma Screening in Chinese Population
Conclusions: PIVKA-II was as efficient as AFP when used as a single marker for HCC screening and the combination of two biomarkers gave a better performance.
Source: Hepatitis Monthly - Category: Infectious Diseases Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Chemistry | Hepatitis | Hepatitis B | Hepatocellular Carcinoma | Infectious Diseases | Liver Cancer | Study | Vitamin K | Vitamins